What is a sessile serrated (precancerous) bowel lesion in an older adult over 50?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Sessile Serrated Bowel Lesion?

A sessile serrated lesion (SSL), also called a sessile serrated polyp (SSP) or sessile serrated adenoma, is a precancerous colon polyp that accounts for up to 30% of colorectal cancers through a distinct molecular pathway separate from conventional adenomas. 1, 2

Key Defining Characteristics

Terminology and Classification:

  • The terms sessile serrated polyp (SSP), sessile serrated adenoma, and sessile serrated lesion (SSL) are synonymous and refer to the same entity 1
  • SSLs are a type of serrated polyp that are not dysplastic initially but can develop foci of dysplasia, at which point they are termed SSL with dysplasia (SSL-d) 1
  • The WHO recently proposed using the term "sessile serrated lesion" as the preferred nomenclature 1

Histologic Features:

  • SSLs show serrated architecture of the crypt lining epithelium with asymmetrical proliferation, irregular crypt shapes with branching, and crypt dilatations especially in the basal portions 3
  • They differ from benign hyperplastic polyps by having abnormal proliferation patterns and architectural distortion 3
  • SSLs typically lack the prominent surface blood vessel pattern seen in conventional adenomas 1

Clinical Significance and Cancer Risk

Malignant Potential:

  • SSLs represent the major precancerous serrated lesion and are found in 8-9% of screening colonoscopies 1, 2, 4
  • They account for 15-30% of all colorectal cancers through the serrated pathway, which involves the CpG island methylator phenotype (CIMP) with BRAF mutations 1, 2, 4
  • Advanced SSLs (≥10 mm or with any dysplasia) are considered to have comparable cancer risk to advanced conventional adenomas 1

Distribution and Detection Challenges:

  • SSLs are predominantly located in the proximal (right) colon, unlike conventional adenomas which are more evenly distributed 1, 2, 4
  • They are typically flat or sessile in shape with few or no surface blood vessels, making them significantly more difficult to detect at colonoscopy than conventional adenomas 1, 2
  • Up to 50% of large SSLs may be incompletely resected with standard techniques, contributing to interval cancer risk 2

Prevalence in Older Adults

Age-Related Findings:

  • In adults aged 45-49 years, clinically significant serrated polyps (including SSLs) are found in 5.9% of screening colonoscopies, similar to the 6.1% rate in those aged 50-54 years 1
  • The prevalence of SSLs remains relatively stable from age 40 onwards, unlike conventional adenomas which increase continuously with age 5

Management Implications

Risk Stratification:

  • SSLs without dysplasia are generally managed like tubular adenomas 1
  • SSL-d (with any grade dysplasia) are managed like high-risk adenomas and may require even more frequent surveillance 1
  • Advanced SSLs are managed similarly to advanced adenomas given their comparable cancer risk 1

Common Pitfall:

  • Pathologist variability exists in differentiating hyperplastic polyps from SSLs, leading to inconsistent reporting 2
  • Endoscopically diagnosed hyperplastic polyps ≥10 mm are sometimes pathologically diagnosed as SSLs and should be considered for resection 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sessile Serrated Polyp Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colon Polyps with Malignant Potential

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.